Who owns CITIUS PHARMACEUTICALS INC COM?
- Ticker: CTXR
- CUSIP Number: 17322u306
Tip: Access positions for across all investors
Analyze quarterly positions in Citius Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Citius Pharmaceuticals stock
Who bought or sold CITIUS PHARMACEUTICALS INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 166k | $206k | 108% | Sep 2025 |
|
| Geode Capital Management | 120k | $149k | 57% | Sep 2025 |
|
| Citadel Advisors | 103k | $128k | 68% | Sep 2025 |
|
| Susquehanna International | 71k | $88k | 55% | Sep 2025 |
|
| BlackRock | 70k | $87k | 0% | Sep 2025 |
|
| Northern Trust | 27k | $34k | 88% | Sep 2025 |
|
| UBS Group | 26k | $32k | -87% | Sep 2025 |
|
| Goss Wealth Management | 25k | $32k | 2% | Sep 2025 |
|
| State Street Corporation | 23k | $29k | 0% | Sep 2025 |
|
| Two Sigma Investments | 22k | $27k | 69% | Sep 2025 |
|
| Arkadios Wealth Advisors | 20k | $25k | 0% | Sep 2025 |
|
| Jane Street | 19k | $23k | 100% | Sep 2025 |
|
| XTX Topco | 16k | $20k | -21% | Sep 2025 |
|
| Cambridge Investment Research Advisors | 10k | $12k | -95% | Sep 2025 |
|
| Simplex Trading | 9.6k | $11k | 100% | Sep 2025 |
|
| IFP Advisors | 7.1k | $8.8k | 0% | Sep 2025 |
|
| Chelsea Counsel | 4.6k | $5.7k | 0% | Sep 2025 |
|
| SBI Securities | 4.0k | $5.0k | 0% | Sep 2025 |
|
| Advisor Group Holdings | 1.5k | $2.0k | -12% | Sep 2025 |
|
| Legacy Wealth Managment | 930.00 | $1.2k | 100% | Sep 2025 |
|
| Luminist Capital | 435.00 | $595.993500 | 0% | Sep 2025 |
|
| Farther Finance Advisors | 343.00 | $425.011300 | 100% | Sep 2025 |
|
| Princeton Global Asset Management | 160.00 | $198.000000 | 0% | Sep 2025 |
|
| Murphy & Mullick Capital Management Corp | 160.00 | $251.008000 | 0% | Sep 2025 |
|
| Smallwood Wealth Investment Management | 120.00 | $147.996000 | 0% | Sep 2025 |
|
| Jpmorgan Chase & Co | 120.00 | $149.004000 | -12% | Sep 2025 |
|
| Quent Capital | 108.00 | $133.995600 | 100% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 107.00 | $133.001000 | 0% | Sep 2025 |
|
| SRS Capital Advisors | 84.00 | $104.000400 | 100% | Sep 2025 |
|
| Federation des caisses Desjardins du Quebec | 80.00 | $99.000000 | 0% | Sep 2025 |
|
| Morgan Stanley | 60.00 | $94.998000 | 100% | Jun 2025 |
|
| Fairscale Capital | 42.00 | $52.000200 | 0% | Sep 2025 |
|
| Wells Fargo & Company | 40.00 | $50.000000 | 100% | Sep 2025 |
|
Who sold out of Citius Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Heights Capital Management | Jun 2025 | 160k | $254k |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | Jun 2025 | 17k | $26k |
| Group One Trading | Jun 2025 | 649.00 | $1.0k |
| Raymond James Financial | Jun 2025 | 226.00 | $359.001000 |
| Larson Financial Group | Jun 2025 | 45.00 | $72.000000 |